惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

V
Visual Studio Blog
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
G
Google Developers Blog
J
Java Code Geeks
爱范儿
爱范儿
Microsoft Azure Blog
Microsoft Azure Blog
美团技术团队
人人都是产品经理
人人都是产品经理
Martin Fowler
Martin Fowler
IT之家
IT之家
博客园_首页
B
Blog RSS Feed
Google DeepMind News
Google DeepMind News
B
Blog
U
Unit 42
Apple Machine Learning Research
Apple Machine Learning Research
L
LangChain Blog
Stack Overflow Blog
Stack Overflow Blog
罗磊的独立博客
N
Netflix TechBlog - Medium
T
Tailwind CSS Blog
博客园 - 聂微东
腾讯CDC
A
About on SuperTechFans

Forbes - Healthcare

The Trump Administration Is Shifting Federal Policy On Cannabis And Psychedelics How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health
UnitedHealth Group Profits Eclipse $6 Billion As Medical ...
Bruce Japsen · 2026-04-21 · via Forbes - Healthcare
United Healthcare CEO Brian Thompson Fatally Shot In Midtown Manhattan

UnitedHealth Group, which is the parent of the nation’s largest health insurer in UnitedHealthcare, on April 21, 2026 raised its full year 2026 earnings outlook to “greater than $17.35 per share,” compared to an earlier forecast of “greater than $17.10 per share.” A general view outside the United Healthcare corporate headquarters on December 4, 2024 in Minnetonka, Minnesota. (Photo by Stephen Maturen/Getty Images)

Getty Images

UnitedHealth Group reported first quarter net income of $6.3 billion as medical costs fell a bit, triggering an improved outlook for the rest of the year.

The company, the parent of UnitedHealthcare, the nation’s largest health insurer, raised its full year 2026 earnings outlook to “greater than $17.35 per share,” compared to an earlier forecast of “greater than $17.10 per share.”

“The first quarter 2026 medical care ratio was 83.9% compared to 84.8% in the first quarter 2025,” the company said of the ratio, which is the percentage of premium revenue that goes toward medical costs. “The year-over-year decrease was driven by strong medical cost management and favorable reserve development, partially offset by consistently elevated utilization and unit cost trends.”

UnitedHealth reported net income of $6.28 billion, or $6.90 per share in the first quarter ended March 31 of this year, compared to $6.29 billon, or $6.85 per share in the year ago quarter. Total company revenues grew 2% to $111.7 billion as the company grew certain Optum businesses including its pharmacy benefit unit OptumRx and benefitted from “repricing” of health insurance products across all of the health plans it sells.

Medical loss ratios have risen to 90% and above for several health insurance companies as claims pile up from doctors and hospitals seeing an influx of patients with a pent up demand for medical care. In UnitedHealth’s fourth quarter of last year, the insurer’s medical care ratio was 91.5%. The industry would prefer such ratios to be below 90% and into the mid 80s, where the industry was less than two years ago.

UnitedHealthcare’s improving medical cost picture comes in part due to decisions by new management to exit unprofitable markets where the company has sold individual coverage under the Affordable Care Act, also known as Obamacare, as well as pulling out of scores of counties where the company no longer sells privatized Medicare Advantage plans. Health insurers including UnitedHealthcare, CVS Health’s Aetna, Humana and Elevance Health all have been struggling to contain medical expenses of a record number of older adults enrolled in Medicare Advantage plans.

The exits from these markets contributed to a loss of health plan members, with UnitedHealthcare serving 49.1 million people in the first quarter of this year compared to 49.8 million people at year-end 2025. “Seniors served through Medicare Advantage, including programs serving complex populations included in Medicaid, declined by 965,000 in the first quarter 2026,” UnitedHealth Group said in its earnings report.

Still, UnitedHealthcare revenues rose to $86.3 billion in the quarter compared to $84.6 billion in the first quarter 2025 as growth in the health insurer’s “employer self-funded offerings partially offset by attrition in both group fully-insured and individual products.”

“UnitedHealthcare’s first quarter 2026 earnings from operations were $5.7 billion compared to $5.2 billion in the first quarter 2025,” the company said in its earnings report. “Operating margin of 6.6% compared to 6.2% in the first quarter 2025, primarily due to repricing across all lines of business in response to cost trends that remain elevated but in line with expectations.”